Relay Therapeutics (RLAY)

Relay Therapeutics (RLAY) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• RLAY last traded at $17.55, -4.36% on the day.
• Relay Therapeutics: P/E -11.2, revenue $11.03M over the last four quarters.
• Over the past year RLAY returned 139.10%; year to date 107.45%.

Updated 2026-11-02 18:01 UTC